Corilip-Neo, rectal suppositories 10 pcs

A combined preparation, the effect of which is determined by the effects of its constituent vitamins and coenzymes, as well as their synergistic action.

Cocarboxylase (coenzyme) catalyzes carboxylation and decarboxylation of α-keto acids, participates in the processes of carbohydrate metabolism.

It mediates the synthesis of nucleic acids, proteins and lipids through participation in the pentose cycle. It corrects metabolic acidosis and cellular hypoxia as well as other metabolic disorders (insufficient functioning of the liver, kidneys, CSS, chronic intoxications).

Riboflavin (vitamin B₂) as a coenzyme of flavin proteins is involved in the regulation of redox reactions (processes of carbohydrate, protein and fat metabolism). It plays an important role in the synthesis of hemoglobin, the maintenance of normal visual function of the eye and the condition of mucous membranes and skin.

Thioctic acid is involved in the oxidative decarboxylation of pyruvic acid and α-keto acids, in the regulation of lipid and carbohydrate metabolism, plays an important role in energy production in the body. Thioctic acid has hepatoprotective effect, improves detoxification function of the liver and protects against exo- and endotoxins.

Corilip-Neo improves tissue metabolism in various physiological and pathological conditions in need of correction by cofactors and substrates.

Indications

For preventive and curative purposes in the treatment of various pathological conditions in children, such as:

• chronic tissue hypoxia;
• reduced immunity;
• bacterial and viral infections, including.
• chronic somatic diseases
• chronic intoxications
• nutritional disorders (hypotrophy) in children.

.

Composition

How to take, the dosage

The drug is used rectally.

Free from the package, insert the suppository in the anus after preliminary bowel emptying.

The suppositories are administered to children under 1 year of age 1 suppository per day.

The course of treatment is 10 days. The total duration of treatment is 3-4 courses with 20 days intervals (3-4 months).

Interaction

No negative interaction has been noted.

The drug can be used in combination therapy.

Special Instructions

Criteria of treatment duration along with clinical condition are cytochemical parameters of activity of peripheral blood leukocyte enzymes (succinate dehydrogenase and glycerophosphate dehydrogenase).

Contraindications

• hypersensitivity reactions to the ingredients of the drug;
• inflammation or bleeding in the rectum (contraindication related to the route of administration)

.

Overdose

Incidents of overdose have not been described.